Philipp Dohnke Partner Corporate and M&A, Intellectual property Primary practice Corporate and M&A, Intellectual property 25/09/2021 Philipp Dohnke | Freshfields Bruckhaus Deringer About Philipp Dohnke <p><strong>Philipp is a member of our intellectual property and information technology team. </strong></p> <p>Since joining the firm, he has worked across many industries with a particular focus on life science and technologies. Philipp has broad expertise in complex, high-profile transactions, including large carve-out and asset deal projects. In addition, Philipp is experienced in drafting and negotiating complex commercial contracts.</p> <div> <p>He speaks German and English.</p> </div> Recent work <ul> <li>Apax and Warburg Pincus on their €5,1bn acquisition of T-Mobile Netherlands</li> <li>Osram on the cave-out and sale of its Digital Systems business in North America to Acuity</li> <li>Thermo Fisher on its €725m acquisition of the viral vector manufacturing business of Novasep (Belgium)</li> <li>AstraZeneca on its $39bn acquisition of Alexion Pharmaceuticals</li> <li>Charterhouse / Serb on the $800m acquisition of the BTG Specialty Pharmaceuticals business from Boston Scientific Corporation</li> <li>Novartis on its $5.2bn acquisition of pharmaceutical product Xiidra from Takeda/Shire</li> <li>Merck on its €3.4bn carve-out und sale of its consumer health business to Procter & Gamble</li> <li>Boehringer Ingelheim on its €18bn business swap with Sanofi (Consumer Healthcare against Animal Health)</li> <li>Boehringer Ingelheim on its sale of rights in the pharmaceutical product Buscopan in Brazil to Hypera</li> <li>AstraZeneca / MedImmune on the acquisition of Definiens AG</li> <li>BioNTech on license deals and other collaborations in the field of mRNA products / individualized medicines (including with Pfizer, Genentech, Sanofi, Eli Lilly, Bayer Animal Health and Genmab)</li> <li>Advent International on the $1.9bn acquisition of Sanofi's generics business (Zentiva) and on the add-on acquisition of Alvogen's CEE business</li> <li>Bridgepoint on the acquisition of Pharmazell (manufacturer of active pharmaceutical ingredients)</li> <li>BC Partners on the €2.6bn acquisition of CeramTec</li> <li>BC Partners on the acquisition of a majority stake in the Greek generics company Pharmathen</li> <li>Charterhouse / Cooper on the acquisition of a consumer health product portfolio from Sanofi</li> <li>Charterhouse / Serb on the acquisition of rights in a pharmaceutical product from a US biotech company</li> <li>CVC on the acquisition of a 50% stake in the pharmaceutical excipient manufacturer DFE Pharma from Fonterra (Joint Venture with FrieslandCampina)</li> <li>Qatar Investment Authority on an investment in the German biotech company CureVac</li> <li>Airbus on a joint venture with Bombardier regarding the aircraft program "C Series" (now "A220") and on the subsequent exit of Bombardier from the joint venture</li> <li>ABB on the carve-out and sale of its cable business to NKT</li> <li>Cinven/Hotelbeds on the acquisition of the Global Travel Distribution business from Kuoni</li> <li>Continental on the carve-out of its powertrain business ("Vitesco Technologies")</li> <li>Deutsche Bank on the carve-out and listing of its Asset Management business ("DWS")</li> <li>H.I.G. on the carve-out and acquisition of the European polyutherane "system house" business from Covestro</li> <li>Hellman & Friedman on its €2.9bn acquisition of the internet platforms AutoScout24, FinanceScout24 und Finanzcheck</li> </ul> Qualifications <p><strong>Education</strong></p> <ul> <li>Bucerius Law School, Hamburg, Germany, and Université25/09/2021 Philipp Dohnkede Paris| FreshfieldsI (Panthéon-Bruckhaus DeringerSorbonne), France (law)</li> Germany, and Université de Paris I (Panthéon-Sorbonne), France (law)</li> <li>Bucerius Law School, Hamburg, Germany (doctorate in law)</li> <li>Traineeship <em>(Referendariat)</em> at the Higher Regional Court of Hamburg, Germany</li> </ul> <p><strong>Professional memberships</strong></p> <ul> <li>German Association for the Protection of Intellectual Property</li> </ul> Contact Philipp [email protected] Hamburg Hohe Bleichen 7 20354 Hamburg T +49 40 36 90 60 F +49 40 36 90 61 55 25/09/2021 Philipp Dohnke | Freshfields Bruckhaus Deringer .